================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   ----------

                                    FORM 10-Q

                QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


For Quarter Ended: September 30, 1997            Commission File Number: 0-19746


                             EcoScience Corporation
             (Exact name of registrant as specified in its charter)

                                    Delaware
         (State or other jurisdiction of incorporation or organization)

                                   04-2912632
                     (I.R.S. Employer Identification Number)

                10 Alvin Court, East Brunswick, New Jersey 08816
          (Address of principal executive offices, including zip code)

                                  732-432-8200
              (Registrant's telephone number, including area code)

Indicate  by check  mark  whether  the  registrant:  (1) has filed  all  reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days.

                                    YES X    NO
                                       ---     ---

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest practicable date.

Class                                           Outstanding at November 12, 1997

Common Stock, par value $0.01 per share         10,451,177

Total Number of Sequentially                    Exhibit Index on Page:  16
Numbered Pages: 28


                                       1

<PAGE>


                             ECOSCIENCE CORPORATION

                            INDEX TO QUARTERLY REPORT

                                  ON FORM 10-Q

                    FOR THE QUARTER ENDED SEPTEMBER 30, 1997

                                   (Unaudited)



                                                                          Page
                                                                          ----

Part I.  -  Financial Information

     Item 1.      Consolidated Financial Statements:
                  Consolidated Balance Sheets -
                    September 30, 1997 and June 30, 1997................    3


                  Consolidated Statements of Operations -
                    Three Months Ended September 30, 1997 and 1996......    4

                  Consolidated Statements of Cash Flows -
                    Three Months Ended September 30, 1997 and 1996......    5


                  Notes to Consolidated Financial Statements............    6

     Item 2.      Management's Discussion and Analysis of Financial
                    Condition and Results of Operations.................    9

Part II.  -  Other Information..........................................   14

Signatures..............................................................   15



                                       2
<PAGE>



                             ECOSCIENCE CORPORATION
                           CONSOLIDATED BALANCE SHEETS
                        (In thousands, except share data)


<TABLE>
<CAPTION>
                                                                                                    September 30,          June 30,
                                                                                                        1997                 1997
                                                                                                    -------------          --------
                                                                                                    (Unaudited)
                                     ASSETS
<S>                                                                                                   <C>                  <C>     
Current assets:
   Cash and cash equivalents .............................................................            $    660             $  1,247
   Short-term investments ................................................................                 533                  528
   Accounts receivable, less reserves of $163 at
       September 30, 1997 and $150 at June 30, 1997 ......................................               1,906                1,788
   Inventories ...........................................................................               2,562                1,940
   Other current assets ..................................................................                 982                  842
                                                                                                      --------             --------
       Total current assets ..............................................................               6,643                6,345
                                                                                                      --------             --------

Property and equipment, net ..............................................................                 704                  562
Intangible assets, net ...................................................................               1,703                1,745
Other noncurrent assets ..................................................................                 220                  223
                                                                                                      --------             --------
           Total assets ..................................................................            $  9,270             $  8,875
                                                                                                      ========             ========


                    LIABILITIES AND STOCKHOLDERS' INVESTMENT

Current liabilities:
   Short-term borrowings .................................................................            $    374             $   --
   Current maturities of long-term debt ..................................................                  14                   10
   Accounts payable ......................................................................               3,230                2,641
   Accrued restructuring costs ...........................................................                 290                  307
   Accrued expenses and other current liabilities ........................................               1,657                1,752
                                                                                                      --------             --------
       Total current liabilities .........................................................               5,565                4,710
                                                                                                      --------             --------

Noncurrent liabilities:
   Long-term debt, less current maturities ...............................................                  11                    1
   Other long-term liabilities ...........................................................                 150                  150
                                                                                                      --------             --------
       Total noncurrent liabilities ......................................................                 161                  151
                                                                                                      --------             --------

Commitments and contingencies ............................................................

Stockholders' investment:
   Preferred stock, $0.01 par value, 1,000,000 shares authorized;
       none issued and outstanding .......................................................                --                   --
   Common stock, $0.01 par value, 25,000,000 shares authorized;
       10,401,177 shares issued and outstanding at September 30,
       1997 and June 30, 1997 ............................................................                 104                  104
   Additional paid-in capital ............................................................              57,222               57,222
   Accumulated deficit ...................................................................             (53,787)             (53,312)
   Unrealized gain on short-term investments .............................................                   5                 --
                                                                                                      --------             --------
       Total stockholders' investment ....................................................               3,544                4,014
                                                                                                      --------             --------
           Total liabilities and stockholders' investment ................................            $  9,270             $  8,875
                                                                                                      ========             ========
</TABLE>




The  accompanying  notes are an integral  part of these  consolidated  financial
statements.



                                       3
<PAGE>



                             ECOSCIENCE CORPORATION
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                    (In thousands, except per share amounts)



                                                         Three Months Ended
                                                            September 30,
                                                       ------------------------
                                                         1997            1996
                                                       --------        --------
                                                              (Unaudited)

Product sales ..................................       $  3,993        $  4,508

Cost of goods sold .............................          3,088           3,405
                                                       --------        --------
Gross profit ...................................            905           1,103
                                                       --------        --------

Operating expenses:
    Research and development ...................            100             128
    Selling and marketing ......................            731             578
    General and administrative .................            553             562
    Reversal of restructuring charge ...........           --               (77)
                                                       --------        --------
          Total operating expenses .............          1,384           1,191
                                                       --------        --------
Operating loss .................................           (479)            (88)
                                                       --------        --------

Other income (expense):
    Research, development, licensing
        fees and other income ..................           --                 7
    Investment income ..........................             17              34
    Interest and other expense .................            (13)            (74)
                                                       --------        --------
          Total other income (expense) .........              4             (33)
                                                       --------        --------
Net loss .......................................       $   (475)       $   (121)
                                                       ========        ========

Net loss per common share ......................       $  (0.05)       $  (0.01)
                                                       ========        ========

Weighted average number of common
     shares outstanding ........................         10,401           9,387
                                                       ========        ========


The  accompanying  notes are an integral  part of these  consolidated  financial
statements.



                                       4
<PAGE>



                             ECOSCIENCE CORPORATION
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                 (In thousands)


<TABLE>
<CAPTION>
                                                                                                           Three Months Ended
                                                                                                               September 30,
                                                                                                       ----------------------------
                                                                                                         1997                 1996
                                                                                                       -------              -------
                                                                                                               (Unaudited)
<S>                                                                                                    <C>                  <C>     
Cash flows from operating activities:
   Net loss ..............................................................................             $  (475)             $  (121)
   Adjustments to reconcile net loss to net
       cash used for operating activities:
           Depreciation and amortization .................................................                  70                   98
           Reversal of restructuring charge ..............................................                --                    (77)
           Foreign exchange loss .........................................................                   4                    7
           Changes in current assets and liabilities:
                Accounts receivable, net .................................................                (118)                (149)
                Inventories ..............................................................                (622)                (287)
                Other current assets .....................................................                (140)                 274
                Accounts payable and accrued expenses ....................................                 490                 (184)
                Accrued restructuring costs ..............................................                 (17)                 (56)
                                                                                                       -------              -------
                   Net cash used for operating activities ................................                (808)                (495)
                                                                                                       -------              -------
Cash flows from investing activities:
   Purchases of property and equipment ...................................................                (170)                 (19)
   Decrease in other noncurrent assets ...................................................                   3                    7
                                                                                                       -------              -------
                   Net cash used for investing activities ................................                (167)                 (12)
                                                                                                       -------              -------

Cash flows from financing activities:
   Proceeds from issuance of stock .......................................................                --                  1,119
   Proceeds from long-term debt ..........................................................                  17                 --
   Net borrowings under line of credit ...................................................                 374                 --
   Payments on long-term debt and capital leases .........................................                  (3)                (988)
                                                                                                       -------              -------
                   Net cash provided by financing activities .............................                 388                  131

Effect of exchange rate changes on cash ..................................................                --                   --
                                                                                                       -------              -------
Decrease in cash and cash equivalents ....................................................                (587)                (376)

Cash and cash equivalents at beginning of period .........................................               1,247                  734
                                                                                                       -------              -------
Cash and cash equivalents at end of period ...............................................             $   660              $   358
                                                                                                       =======              =======

Total unrestricted and restricted cash, cash equivalents
   and short-term investments at end of period ...........................................             $ 1,193              $ 2,265
                                                                                                       =======              =======


Supplemental cash flow information 
Cash paid for:
       Interest ..........................................................................             $     5              $    88
       Income taxes ......................................................................                   1                   11

Non-cash investing and financing activities:
       Disposition of equipment under capital lease ......................................                --                    308
       Termination of capital lease obligations ..........................................                --                 (1,248)
</TABLE>

The  accompanying  notes are an integral  part of these  consolidated  financial
statements.



                                       5
<PAGE>



                             ECOSCIENCE CORPORATION

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                               September 30, 1997
                                   (Unaudited)


1.   OPERATIONS

     EcoScience  Corporation  ("EcoScience")  and its wholly owned  subsidiaries
(collectively, the "Company"), Agro Dynamics, Inc. and Agro Dynamics Canada Inc.
(collectively, "AGRO") and EcoScience Produce Systems Corp. ("EPSC") are engaged
in the technical marketing, sales, development and commercialization of products
and services for the following major markets:  (i) specialty  agriculture;  (ii)
postharvest  fruits and  vegetables;  and (iii)  biological  insect  control for
professional  pest  control  operators   ("PCOs").   The  Company  provides  (i)
sophisticated  growing  systems to greenhouse  operators,  (ii)  technologically
advanced  sorting,  grading  and  packing  systems  to  produce  packers,  (iii)
equipment,  coatings and disease control products, including natural biologicals
for  protecting  fruits,  vegetables  and  ornamentals in storage and transit to
market, and (iv) a unique biological pest control product to PCOs.

     The Company  derives most its revenues from the sale of (i) growing  medium
products to the North American  intensive  farming and horticulture  industries;
(ii) sorting,  grading and packing systems to the produce packing industry;  and
(iii)  postharvest  coating  products to the fresh fruit and  vegetable  markets
throughout the western hemisphere.

     The  Company  is  subject  to a number of risks  similar  to those of other
companies  in  similar  stages  of  development,  including  dependence  on  key
individuals,  competition  from other products and  companies,  the necessity to
develop,  register, and manufacture commercially usable products, the ability to
achieve  profitable  operations and the need to raise  additional  funds through
public or private debt or equity financing.

     The Company believes cash reserves of $660,000 of cash and cash equivalents
and $533,000 of  short-term  investments  as of September  30, 1997,  along with
revenues from product  sales,  and funds  available  under its revolving line of
credit will be sufficient to fund the Company's  working capital needs,  planned
capital expenditures, restructuring program initiatives and related obligations,
and to service its indebtedness through September 30, 1998. The Company may need
to raise additional funds to finance its ongoing  operations and expected growth
after  September 30, 1998,  although there can be no assurances  that such funds
will be available on terms  favorable to the Company.  The Company is continuing
to explore  potential  mergers,  joint  ventures  and  various  other  strategic
opportunities,  which are aimed at enhancing stockholder value and the long-term
commercial viability of the Company.

2.   BASIS OF PRESENTATION

     The  accompanying  unaudited  consolidated  financial  statements have been
prepared by the Company and reflect all  adjustments,  consisting of only normal
recurring adjustments, which are, in the opinion of management,  necessary for a
fair  presentation of financial results for the three months ended September 30,
1997 and 1996, in accordance with generally accepted  accounting  principles for
interim  financial  reporting  and  pursuant  to Article 10 of  Regulation  S-X.
Certain information



                                       6
<PAGE>



and footnote  disclosures  normally  included in the  Company's  annual  audited
consolidated  financial  statements  have been condensed or omitted  pursuant to
such rules and regulations.

     The results of operations for the three months ended September 30, 1997 and
1996 are not necessarily  indicative of the results of operations to be expected
for a full fiscal year. These interim  consolidated  financial statements should
be read in conjunction with the audited  consolidated  financial  statements for
the fiscal year ended June 30, 1997,  which are included in the Company's Annual
Report on Form 10-K filed with the Securities and Exchange Commission.

     The accompanying  interim  consolidated  financial  statements  include the
accounts of the Company and its  wholly-owned  subsidiaries,  AGRO and EPSC. All
material  intercompany   transactions  and  balances  have  been  eliminated  in
consolidation. The financial statements for the three months ended September 30,
1996 contain certain reclassifications to conform with the current year basis of
presentation.

     The  preparation  of financial  statements  in  conformity  with  generally
accepted  accounting  principles  requires  management  to  make  estimates  and
assumptions  that  affect the  reported  amounts of assets  and  disclosures  of
contingent  assets and liabilities as of the dates of the financial  statements,
and the reported amounts of revenues and expenses during the reporting  periods.
Actual results could differ from those estimates.


3.   INVENTORIES

     Inventories are stated at the lower of first-in,  first-out  (FIFO) cost or
market and consist of the following:

                                                    September 30,      June 30,
(In thousands)                                          1997             1997
                                                       ------           ------
Raw materials ............................             $   51           $   17
Finished goods ...........................              2,511            1,923
                                                       ------           ------
                                                       $2,562           $1,940
                                                       ======           ======

     Finished goods include material, labor and manufacturing overhead costs.


4.   NET LOSS PER SHARE

     Net loss per share is computed using the weighted  average number of common
shares  outstanding.  Common equivalent shares are not included in the per share
calculations, as the effect of their inclusion would be anti-dilutive.

     In March 1997, the Financial Accounting Standards Board issued Statement of
Financial Accounting Standards No. 128, "Earnings Per Share" ("SFAS 128"), which
makes  certain  changes to the manner in which  earnings  per share is reported.
SFAS 128 is  effective  for  financial  statements  for both  interim and annual
periods ending after December 15, 1997 and early adoption is not



                                       7
<PAGE>



permitted.  The Company will adopt this standard for the period ending  December
31, 1997. The adoption of this standard will require restatement of prior years'
earnings per share.

     If the Company had adopted SFAS 128 for the three  months  ended  September
30,  1997,  basic loss per share would have been  ($0.05),  based on  10,401,000
basic weighted average shares.

















                                       8
<PAGE>



                             ECOSCIENCE CORPORATION

                MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL
                       CONDITION AND RESULTS OF OPERATIONS


GENERAL

     EcoScience is engaged in the technical  marketing,  sales,  development and
commercialization  of products and services for the following major markets: (i)
specialty  agriculture;  (ii)  postharvest  fruits  and  vegetables;  and  (iii)
biological insect control for professional pest control operators ("PCOs").

          Specialty Agriculture

     The  Company  engineers,  designs,  markets and  distributes  sophisticated
growing  systems and services to the greenhouse and nursery market in the United
States,  Canada and Mexico.  The Company's primary products for this market are:
(i)  advanced  growing  systems  based on  Stonewool(R)  inert  growing  medium,
manufactured by Grodania A/S, (ii)  computerized  environmental,  irrigation and
fertigation control systems  manufactured by H. Hoogendorn  Automation B.V., and
(iii) multiple greenhouse consumable products.

     The Company and Grodania  A/S  executed an extension of their  distribution
agreement  which  provides  for  the  Company's  exclusive  distribution  of the
Grodan(R)  brand of  stonewool  in the  United  States,  Canada,  Mexico and the
Caribbean, dated September 29, 1997, covering the period January 1, 1998 through
December 31, 2000,  and which  provides for  automatic one year  extensions,  as
defined.

          Postharvest Fruits and Vegetables

     The fruit and vegetable production industry requires specialized  services,
equipment and products for the  harvesting,  processing  and storage of produce.
The Company  provides  equipment,  coatings and disease control  products to the
fruit,  vegetable and ornamental packing markets. The Company's primary products
for this market are: (i) technologically  advanced sorting,  grading and packing
systems  for produce  packers,  manufactured  by Aweta,  B.V.,  (ii)  equipment,
coatings and disease control  products for the protection of fruits,  vegetables
and ornamentals in storage and transit to market including PacRite(R) and Indian
River Gold(TM) coatings  manufactured by EPSC, and the Bio-Save(TM)  PostHarvest
BioProtectant line of natural biological products.

          Biological Insect Control

     In the biological insect control market,  the Company,  with  collaborative
partners,   has  been  focused  on   developing   and  selling  cost   effective
bioinsecticide  alternatives  to  synthetic  chemical  insecticides  for  use in
specific  applications,  including  sensitive  use  environments  such as homes,
restaurants,  schools and food  processing  facilities.  The  Company's  primary
product  for  this  market  is  Bio-Blast(R)  Biological  Termiticide,  a unique
biological pest control product manufactured by EcoScience.

     The Company sells Bio-Blast to PCO's through a marketing collaboration with
Terminix.  In fiscal 1997, the Company  initiated the U.S.  commercial launch of
Bio-Blast in collaboration with Terminix. Additionally, EcoScience has initiated
an extensive testing, development and marketing



                                       9
<PAGE>



program  with Maruwa  BioChemical  and Shinto  Paint Co.,  Ltd.  for  biological
products in Japan.  The Company  commenced  shipments  of Bio-Blast to Maruwa in
fiscal 1997.

     The Company's  technology is used for the  development  and  application of
natural  microbial  pest control agents and coatings to sustain the freshness of
fruits and vegetables.  The Company's technology enables it to provide technical
support  for  growers  and packers of  specialty  crops.  The  Company  conducts
research on the use of  microbial  agents to control  plant  diseases and insect
pests, as well as on new applications for natural coatings to sustain  nutrition
and overall  quality in fresh  fruits and  vegetables.  The  Company  expects to
conduct tests to determine the possibility of extending the range of performance
and  applicability  for both its  Bio-Save  line of products  and its  Bio-Blast
insect control product.

     The Company  derives most its revenues from the sale of (i) growing  medium
products to the North American  intensive  farming and horticulture  industries;
(ii) sorting,  grading and packing systems to the produce packing industry;  and
(iii)  postharvest  coating  products to the fresh fruit and  vegetable  markets
throughout the western hemisphere.


RESULTS OF OPERATIONS

                    Three Months Ended September 30, 1997 vs.
                      Three Months Ended September 30, 1996

     The Company's product sales decreased $515,000 or 11% to $3,993,000 for the
three months ended  September  30, 1997 from  $4,508,000  for the same period in
1996.  This  decrease was  primarily due to the decrease in product sales in the
Postharvest  Fruits and  Vegetables  market of  $535,000  and in the  Biological
Insect  Control  market of  $101,000,  offset by an  increase  in the  Specialty
Agriculture  market of $121,000.  The  following  table sets forth the Company's
product sales by market for the three months ended September 30, 1997 and 1996:

                                                Three Months Ended September 30,
                                                ------------------------------
                                                                      Increase
(In thousands)                                   1997        1996    (Decrease)
                                                ------      ------    --------
Specialty Agriculture .....................     $2,668      $2,547    $  121
Postharvest Fruits and Vegetables .........      1,325       1,860      (535)
Biological Insect Control .................       --           101      (101)
                                                ------      ------    ------ 
Consolidated ..............................     $3,993      $4,508    ($ 515)
                                                ======      ======    ======

     The Company is the exclusive distributor in the United States and Canada of
the Grodan brand of stonewool, an inert growing medium supplied by Grodania A/S,
a Denmark based company. In August 1995, the Company entered into a distribution
agreement with Aweta B.V., a Netherlands based company,  for the exclusive right
to sell Aweta B.V.'s sorting,  grading and packing products and equipment to the
fruit, vegetable and flower markets in the United States, Canada, Mexico and the
Caribbean.   The  Company  believes  that  revenues  under  these   distribution
agreements  will each  account for more than 10% of the  Company's  consolidated
product  sales for the fiscal year ending June 30,  1998.  Although  there are a
limited number of sources of growing medium products,  and sorting,  grading and
packing equipment  manufacturers in the world, the Company's management



                                       10
<PAGE>



believes  that other  suppliers  could  provide such  products and  equipment on
comparable  terms. A change in supplier,  however could cause a delay in filling
orders as well as a possible loss of sales, which would affect operating results
adversely.

     Cost of goods sold  decreased  $317,000 or 9% to  $3,088,000  for the three
months  ended  September  30, 1997 from  $3,405,000  for the same period in 1996
primarily due to product sales decreases.

     Gross margin on product sales decreased $198,000 or 18% to $905,000 for the
three months ended  September  30, 1997 from  $1,103,000  for the same period in
1996,  while gross margin  percentage on product sales  decreased to 23% for the
three months ended  September 30, 1997 from 24% for the same period in 1996. The
decrease in gross margin percentage was primarily due to decreases in biological
and coatings product sales which typically have higher gross margin  percentages
than Specialty Agriculture products.

     Research and development  expenses decreased $28,000 or 22% to $100,000 for
the three months ended  September  30, 1997 from $128,000 for the same period in
1996,  due primarily to reductions  in personnel  and related  costs,  partially
offset by decreases in costs allocable to production of the Company's biological
products.  The  Company  has and will  continue to incur  ongoing  research  and
development  expenses  for its  Bio-Save  PostHarvest  BioProtectant,  Bio-Blast
Biological Termiticide and other select programs in fiscal 1998.

     Selling and marketing  expenses  increased  $153,000 or 26% to $731,000 for
the three months ended  September  30, 1997 from $578,000 for the same period in
1996, due primarily to additional  personnel,  promotional  and related costs to
support  efforts to increase  market  penetration  and the marketing of expanded
product lines.

     General and administrative  expenses decreased $9,000 or 2% to $553,000 for
the three months ended  September  30, 1997 from $562,000 for the same period in
1996,  primarily  due to decreases in  professional  fees and  insurance  costs,
partially offset by increases in personnel costs.

     Operating  loss  increased  $391,000 to a loss of ($479,000)  for the three
months ended  September 30, 1997 compared to an operating  loss of ($88,000) for
the same period in 1996. The increase in operating loss resulted from a $198,000
decrease in gross profits for the three months ended September 30, 1997 compared
to the same  period in 1996,  and a $193,000  increase  in  operating  expenses.
Excluding non-recurring amounts in 1996, the operating loss for the three months
ended September 30, 1997 increased $314,000 to ($479,000) from an operating loss
of ($165,000) for the same period in 1996,  after  exclusion of a  non-recurring
reversal of accrued  restructuring costs of $77,000 in 1996.  Operating expenses
increased  $116,000 or 9% to $1,384,000 for the three months ended September 30,
1997 compared to $1,268,000 for the same period in 1996, when the  restructuring
reversal is excluded for 1996.

     Other income / (expense) improved by $37,000 to $4,000 net other income for
the three months ended  September 30, 1997 compared to ($33,000) net expense for
the same period in 1996. The decrease was primarily  attributable to a reduction
in interest and other expenses of $61,000 or 82%,  primarily due to the decrease
in interest expense resulting from the lower average level of long-term debt and
capital lease  obligations  outstanding  during the three months ended September
30, 1997 compared to the same period in 1996; partially offset by (i) a decrease
in investment  income of $17,000  resulting  from a decline in the average funds
available for  investment in the three months



                                       11
<PAGE>



ended  September 30, 1997 compared to the same period in 1996 and (ii) $7,000 in
research and development revenue recorded in 1996 compared to none in 1997.

     The Company's net loss increased  $354,000 or $0.04 per share to a net loss
of ($475,000) or ($0.05) per share for the three months ended September 30, 1997
compared to a net loss of ($121,000) or ($0.01) per share for the same period in
1996. Excluding  non-recurring  amounts, the net loss for the three months ended
September 30, 1997 was  ($475,000) or ($0.05) per share, a $277,000 or $0.03 per
share increase,  compared to the net loss of ($198,000) or ($0.02) per share for
the same  period in 1996,  when the $77,000  reversal  of accrued  restructuring
costs is excluded from 1996.

LIQUIDITY AND CAPITAL RESOURCES

     The Company's  operations  have been funded  through  revenues from product
sales,  public and private placements of its equity  securities,  bank loans and
lease   financings,   licensing,    collaborative   research   and   development
arrangements, and investment income.

     Cash and cash  equivalents  were $660,000 at September 30, 1997 compared to
$1,247,000 at June 30, 1997. Cash, cash  equivalents and short-term  investments
totaled  $1,193,000  at September  30, 1997  compared to  $1,775,000 at June 30,
1997. Cash used for operating  activities  totaled $808,000 for the three months
ended  September  30,  1997  and was  principally  represented  by a net loss of
($475,000)  and an increase in  inventory of  $622,000,  partially  offset by an
increase in accounts payable and accrued expenses of $490,000.  Cash provided by
financing  activities  totaled  $388,000 in the three months ended September 30,
1997,  which  consisted  principally  of  net  borrowings  under  the  Company's
revolving line of credit of $374,000.  Cash used for  investment  activities for
the three months ended  September  30, 1997 totaled  $167,000,  which  consisted
principally  of purchases of property and  equipment of $170,000.  The Company's
working capital and current ratio were $1,078,000 and 1.2 to 1, respectively, at
September 30, 1997 compared to $1,635,000  and 1.3 to 1,  respectively,  at June
30, 1997.

     Debt  increased by $388,000 to $399,000 at September  30, 1997  compared to
$11,000 at June 30, 1997.  The increase was due to seasonal  financing  needs at
September 30, 1997. The amount  available under the Company's  revolving line of
credit was $1,736,000 at September 30, 1997.

     In the three months ended September 30, 1997, the Company funded $17,000 of
accrued  restructuring costs that had been recorded in fiscal 1994 and 1995. The
balance of accrued  restructuring costs,  $440,000 (total current and noncurrent
portions),  as of September  30, 1997, is expected to be utilized in fiscal 1998
and thereafter.

     The  Company  expects to incur  administrative,  business  development  and
commercialization  expenditures  in the future as it advances  the  development,
manufacturing  and marketing of its Bio-Blast and Bio-Save  products,  and other
select development programs in its bio-technology  operations.  In addition, the
Company expects to incur  incremental  costs associated with its plans to expand
product lines  offerings.  The Company may also use cash to acquire  technology,
products or companies that support the strategy of the Company.

     The Company plans to finance its cash needs  principally with existing cash
reserves, represented by approximately $660,000 of cash and cash equivalents and
$533,000  of  short-term  investments  as of



                                       12
<PAGE>



September 30, 1997.  The Company  believes that such cash  reserves,  along with
revenues from product  sales,  and funds  available  under its revolving line of
credit, will be sufficient to fund the Company's working capital needs,  planned
capital expenditures, restructuring program initiatives and related obligations,
and to service its indebtedness through September 30, 1998. The Company may need
to raise additional funds to finance its ongoing  operations and expected growth
after  September 30, 1998,  although there can be no assurances  that such funds
will be available on terms  favorable to the Company.  The Company is continuing
to explore  potential  mergers,  joint  ventures  and  various  other  strategic
opportunities,  which are aimed at enhancing stockholder value and the long-term
commercial viability of the Company.

SEASONALITY

     The timing of the Company's  operating revenues may vary as a result of the
seasonal  nature of its  businesses.  In  addition,  operating  revenues  may be
affected  by the timing of new product  launches,  acquisitions,  sales  orders,
sales product mix,  completion of systems and equipment  installations and other
economic factors. Operating revenues may be concentrated in the Company's second
and fourth  quarters as a result of the North  American  growing and  harvesting
seasons.  Although the Company  believes that the historical  trend in quarterly
revenues for the second and fourth  quarters of each year are  generally  higher
than the first  and third  quarters;  there can be no  assurance  that this will
occur in future periods. Accordingly,  quarterly or other interim results should
not be considered  indicative of results to be expected for any other quarter or
for the full fiscal year.

FORWARD LOOKING STATEMENTS

     This report contains forward looking statements that describe the Company's
business prospects.  These statements involve risks and uncertainties including,
but not limited to,  regulatory  uncertainty,  level of demand for the Company's
products and services,  product acceptance,  industry wide competitive  factors,
seasonality  factors,  timing of  completion  of major  equipment  projects  and
political, economic or other conditions.  Furthermore, market trends are subject
to changes, which could adversely affect future results.



                                       13
<PAGE>



                           Part II. OTHER INFORMATION



Item 1.           Legal Proceedings
                  None

Item 2.           Changes in Securities
                  None

Item 3.           Defaults Upon Senior Securities
                  None

Item 4.           Submission of Matters to a Vote of Security Holders
                  None

Item 5.           Other Information
                  None

Item 6.           Exhibits and Reports on Form 8-K
                  a.   Exhibits

                       Exhibit               Exhibit
                       Number                Description
                       ------           ----------------------------------------
                       10.57            Agreement  between Agro  Dynamics,  Inc.
                                        and Grodania  A/S,  dated  September 29,
                                        1997, with certain confidential material
                                        omitted.

                       27               Financial  Data  Schedule  as of and for
                                        the Three  Months  Ended  September  30,
                                        1997.


                  b.   Reports on Form 8-K.
                       None.




                                       14
<PAGE>



                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned, thereunto duly authorized.


                                   ECOSCIENCE CORPORATION


Date:  November 14, 1997           By: /s/ Michael A DeGiglio
                                      ------------------------
                                      Michael A. DeGiglio
                                      President and Chief Executive Officer
                                      (Principal Executive Officer)



Date:  November 14, 1997           By: /s/ Harold A. Joannidi
                                      ------------------------
                                      Harold A. Joannidi
                                      Treasurer & Secretary
                                      (Principal Financial & Accounting Officer)








                                       15
<PAGE>





                             ECOSCIENCE CORPORATION

                                  EXHIBIT INDEX



Exhibit Number                 Description of Exhibit                Page Number
--------------                 ----------------------                -----------

     10.57       Agreement between Agro Dynamics, Inc.                    17
                   and Grodania A/S, dated September 29,
                   1997, with certain confidential material
                   omitted

       27        Financial Data Schedule as of and for the                28
                   Three Months Ended September 30, 1997













                                       16